Company Filing History:
Years Active: 2019
Title: Camille Aubry: Innovator in Probiotics and Therapeutics
Introduction
Camille Aubry is a prominent inventor based in Saint Germain-en-Laye, France. She has made significant contributions to the field of biotechnology, particularly in the development of probiotics and therapeutic agents. Her innovative work focuses on the use of recombinant bacteria for medical applications.
Latest Patents
Aubry holds a patent for her invention titled "Lactococcus lactis producing TSLP or IL-25 and their uses as probiotics and therapeutics." This patent describes recombinant bacteria that express and secrete TSLP or IL-25, or a combination of both. The invention aims to utilize these bacteria as probiotics or therapeutic agents, especially for treating inflammatory diseases and disorders. She has 1 patent to her name.
Career Highlights
Throughout her career, Camille Aubry has been dedicated to advancing the understanding and application of probiotics in medicine. Her work has garnered attention for its potential to improve health outcomes in patients suffering from various inflammatory conditions.
Collaborations
Aubry has collaborated with notable colleagues in her field, including Philippe Langella and Jean-Marc Chatel. These partnerships have contributed to the advancement of her research and the successful development of her patented technologies.
Conclusion
Camille Aubry is a trailblazer in the field of probiotics and therapeutics, with her innovative patent showcasing the potential of recombinant bacteria in medical applications. Her contributions continue to influence the landscape of biotechnology and healthcare.